Survival analysis in breast cancer using proteomic data from four independent datasets
Abstract Breast cancer clinical treatment selection is based on the immunohistochemical determination of four protein biomarkers: ESR1, PGR, HER2, and MKI67. Our aim was to correlate immunohistochemical results to proteome-level technologies in measuring the expression of these markers. We also aime...
Saved in:
Main Authors: | Ágnes Ősz, András Lánczky, Balázs Győrffy |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/98b06f65bfd74ceea979747b3df6d25b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.
by: Balázs Győrffy, et al.
Published: (2013) -
Pancancer survival analysis of cancer hallmark genes
by: Ádám Nagy, et al.
Published: (2021) -
Enhanced differential expression statistics for data-independent acquisition proteomics
by: Tomi Suomi, et al.
Published: (2017) -
Dynamic Urinary Proteome Changes in Ovalbumin-Induced Asthma Mouse Model Using Data-Independent Acquisition Proteomics
by: Qin W, et al.
Published: (2021) -
3p Arm Loss and Survival in Head and Neck Cancer: An Analysis of TCGA Dataset
by: Hugh Andrew Jinwook Kim, et al.
Published: (2021)